BCL2 and hepatocellular carcinoma: Bcl‐2 overexpression is a hallmark of HCC resistance to chemotherapy, as it inhibits mitochondrial outer membrane permeabilization (MOMP), preventing cytochrome c release and apoptotic cascade activation [64].